결과 페이지 12 - 부문: 보건의료 업종: 생명공학 주식 시장 - 시세 및 가격
가격, 시가 총액, PE 및 EPS가 포함된 모든 주식 목록
모든 나라들
모든 거래소
- {{item.name}}
- 모든 거래소
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
보건의료 (2611)
- {{item.name}}
- 모든 업종
- 보건의료 (2611)
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 |
|---|
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Sino Biopharmaceutical SBHMY | $8.79 — |
0
|
$8.33B — | $100 — | $10.3 — | $10.3 — | $8.33B — | 30.31 | $0.29 — | |
| Cerevel Therapeutics CERE | $44.96 — |
0
|
$8.19B — | $0 — | $0 — | $0 — | $8.19B — | 0 | $0 — | |
| Bio-Techne Corporation TE1.F | $43.8 47.88 USD |
+0.46
|
$7.03B 7.68B USD | $176 192.39 USD | $43.8 47.88 USD | $43.8 47.88 USD | $7.03B 7.68B USD | 50.34 | $0.87 0.95 USD | |
| Verona Pharma plc I9SA.F | $49 53.56 USD |
-0.41
|
$6.84B 7.48B USD | $323 353.08 USD | $49 53.56 USD | $49 53.56 USD | $6.84B 7.48B USD | 0 | -$1.91 -2.08 USD | |
| Exelixis, Inc. EX9.DE | $21.09 23.05 USD |
0
|
$6.79B 7.42B USD | $0 0 USD | $0 0 USD | $0 0 USD | $6.79B 7.42B USD | 0 | $0 0 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $51.96 56.8 USD |
-2.4
|
$6.42B 7.02B USD | $300 327.94 USD | $51.96 56.8 USD | $51.96 56.8 USD | $6.42B 7.02B USD | 17.09 | $3.04 3.32 USD | |
| Roivant Sciences Ltd. 87S.F | $8.69 9.5 USD |
-0.89
|
$6.28B 6.86B USD | $600 655.88 USD | $8.69 9.5 USD | $8.78 9.59 USD | $6.28B 6.86B USD | 0 | -$0.89 -0.9 USD | |
| Sarepta Therapeutics, Inc. S1RP34.SA | $15.87 3.22 USD |
+7.3
|
$33.07B 6.7B USD | $2 0.41 USD | $15.87 3.22 USD | $16 3.24 USD | $33.07B 6.7B USD | 23.00 | $0.69 0.14 USD | |
| Corcept Therapeutics Incorporated HTD.F | $56.72 62 USD |
+0.64
|
$6.07B 6.64B USD | $6 6.56 USD | $56.72 62 USD | $56.72 62 USD | $6.07B 6.64B USD | 52.03 | $1.09 1.19 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $17.8 19.46 USD |
0
|
$6.03B 6.59B USD | $15 16.4 USD | $17.8 19.46 USD | $17.8 19.46 USD | $6.03B 6.59B USD | 0 | -$4.36 -4.7 USD | |
| Revolution Medicines, Inc. 42Z.F | $31.6 34.54 USD |
0
|
$5.96B 6.52B USD | $50 54.66 USD | $31.6 34.54 USD | $31.6 34.54 USD | $5.96B 6.52B USD | 0 | -$3.17 -3.4 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $264.9 289.57 USD |
-1.12
|
$5.95B 6.51B USD | $99 108.22 USD | $262.2 286.62 USD | $270.5 295.69 USD | $5.95B 6.51B USD | 0 | -$19.39 -21.2 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $29.87 32.65 USD |
+0.98
|
$5.76B 6.29B USD | $380 415.39 USD | $29.8 32.58 USD | $29.87 32.65 USD | $5.76B 6.29B USD | 0 | -$2.55 -2.7 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $91.7 100.24 USD |
+3.1
|
$5.63B 6.16B USD | $10 10.93 USD | $88.72 96.98 USD | $91.7 100.24 USD | $5.63B 6.16B USD | 11.97 | $7.66 8.37 USD | |
| SK Biopharmaceuticals Co., Ltd. 326030.KS | $104,000 78.5 USD |
+1.36
|
$8.14T 6.15B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.14T 6.15B USD | 0 | $0 0 USD | |
| Ionis Pharmaceuticals, Inc. IONS.MX | $647 38.31 USD |
0
|
$102.85B 6.09B USD | $0 0 USD | $647 38.31 USD | $647 38.31 USD | $102.85B 6.09B USD | 0 | -$61.21 -3.6 USD | |
| Legend Biotech Corporation 9LB.F | $28.6 31.26 USD |
-2.72
|
$5.29B 5.79B USD | $135 147.57 USD | $28.4 31.05 USD | $29.4 32.14 USD | $5.29B 5.79B USD | 0 | -$0.85 -0.9 USD | |
| TG Therapeutics, Inc. NKB2.F | $33.29 36.39 USD |
-1.63
|
$5.23B 5.72B USD | $61 66.68 USD | $33.29 36.39 USD | $33.29 36.39 USD | $5.23B 5.72B USD | 256.03 | $0.13 0.14 USD | |
| Telix Pharmaceuticals TLPPF | $16.95 — |
-5.57
|
$5.67B — | $8.05K — | $16.8 — | $17.2 — | $5.67B — | 188.33 | $0.09 — | |
| ALK-Abelló A/S AKBLF | $22.35 — |
0
|
$5.59B — | $100 — | $22.35 — | $22.35 — | $5.59B — | 39.91 | $0.56 — | |
| Financière de Tubize SA FTD.SG | $109.4 119.59 USD |
+0.74
|
$5.1B 5.58B USD | $0 0 USD | $109.4 119.59 USD | $110.8 121.12 USD | $5.1B 5.58B USD | 54.15 | $2.02 2.21 USD | |
| Abcam ABCM | $23.99 — |
0
|
$5.52B — | $0 — | $0 — | $0 — | $5.52B — | 0 | $0 — | |
| Financière de Tubize SA FTD.F | $110.6 120.9 USD |
-0.72
|
$5.03B 5.5B USD | $70 76.52 USD | $110.6 120.9 USD | $110.6 120.9 USD | $5.03B 5.5B USD | 54.48 | $2.03 2.22 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Blueprint Medicines Corporation 2L9.F | $71.32 77.96 USD |
+3.12
|
$4.79B 5.24B USD | $30 32.79 USD | $71.32 77.96 USD | $72.38 79.12 USD | $4.79B 5.24B USD | 0 | -$0.95 -1.03 USD | |
| Abcam ABCZF | $22.25 — |
+0.68
|
$5.12B — | $4K — | $22.25 — | $22.25 — | $5.12B — | 2225.00 | $0.01 — | |
| Sarepta Therapeutics, Inc. AB3A.F | $47.34 51.75 USD |
+0.23
|
$4.65B 5.08B USD | $12 13.12 USD | $47.34 51.75 USD | $47.34 51.75 USD | $4.65B 5.08B USD | 22.86 | $2.07 2.26 USD | |
| Axsome Therapeutics, Inc. 19X.F | $91.8 100.35 USD |
+2.25
|
$4.61B 5.04B USD | $231 252.51 USD | $91.8 100.35 USD | $91.8 100.35 USD | $4.61B 5.04B USD | 0 | -$5.31 -5.8 USD | |
| Halozyme Therapeutics, Inc. HALO.MX | $680 40.26 USD |
0
|
$84B 4.97B USD | $0 0 USD | $680 40.26 USD | $680 40.26 USD | $84B 4.97B USD | 21.27 | $31.96 1.89 USD | |
| ALK-Abelló A/S 4AJ0.F | $19.72 21.56 USD |
+0.2
|
$4.42B 4.83B USD | $100 109.31 USD | $19.72 21.56 USD | $19.72 21.56 USD | $4.42B 4.83B USD | 40.24 | $0.49 0.54 USD | |
| Biocon Limited BIOCON.BO | $331.2 4.01 USD |
+0.65
|
$396.8B 4.8B USD | $44.18K 534.55 USD | $328.05 3.97 USD | $332.95 4.03 USD | $396.8B 4.8B USD | 49.35 | $6.71 0.08 USD | |
| Krystal Biotech, Inc. 4KB.SG | $145.15 158.67 USD |
-0.96
|
$4.19B 4.59B USD | $0 0 USD | $145.15 158.67 USD | $145.15 158.67 USD | $4.19B 4.59B USD | 54.77 | $2.65 2.9 USD | |
| Zealand Pharma A/S ZLDPF | $64.82 — |
+3.71
|
$4.58B — | $600 — | $64.82 — | $66 — | $4.58B — | 0 | -$2.47 — | |
| Krystal Biotech, Inc. 4KB.F | $145 158.5 USD |
-1.19
|
$4.19B 4.58B USD | $17 18.58 USD | $145 158.5 USD | $145 158.5 USD | $4.19B 4.58B USD | 54.51 | $2.66 2.91 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
| Alpine Immune Sciences ALPN | $64.97 — |
0
|
$4.46B — | $0 — | $0 — | $0 — | $4.46B — | 0 | $0 — | |
| Ionis Pharmaceuticals, Inc. ISI.F | $24.91 27.23 USD |
+1.14
|
$4.04B 4.41B USD | $4 4.37 USD | $24.91 27.23 USD | $24.91 27.23 USD | $4.04B 4.41B USD | 0 | -$2.69 -2.9 USD | |
| ALK-Abelló A/S 0OIR.IL | $149.45 21.91 USD |
0
|
$30B 4.4B USD | $56.7K 8.31K USD | $148.6 21.79 USD | $148.6 21.79 USD | $30B 4.4B USD | 92.82 | $1.61 0.24 USD | |
| Cytokinetics, Incorporated KK3A.F | $32.2 35.2 USD |
-4.17
|
$3.96B 4.33B USD | $59 64.49 USD | $32.2 35.2 USD | $32.2 35.2 USD | $3.96B 4.33B USD | 0 | -$4.66 -5.09 USD | |
| Agios Pharmaceuticals, Inc. AGIO.MX | $1,222 72.36 USD |
0
|
$70.02B 4.15B USD | $0 0 USD | $1,222 72.36 USD | $1,222 72.36 USD | $70.02B 4.15B USD | 5.16 | $236.58 14.01 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Mirati Therapeutics MRTX | $58.7 — |
0
|
$4.12B — | $0 — | $0 — | $0 — | $4.12B — | 0 | $0 — | |
| BB Biotech AG BB.MI | $65.2 71.27 USD |
0
|
$3.58B 3.91B USD | $10.08K 11.02K USD | $51.6 56.41 USD | $52.9 57.83 USD | $3.58B 3.91B USD | 5.75 | $11.32 12.37 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $53.5 58.48 USD |
+1.9
|
$3.5B 3.83B USD | $11 12.02 USD | $53.5 58.48 USD | $54 59.03 USD | $3.5B 3.83B USD | 0 | -$3.84 -4.1 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| CymaBay Therapeutics CBAY | $32.48 — |
0
|
$3.73B — | $0 — | $0 — | $0 — | $3.73B — | 0 | $0 — | |
| Zealand Pharma A/S 0NZU.IL | $419.25 61.47 USD |
0
|
$25B 3.67B USD | $10.41K 1.53K USD | $428.44 62.82 USD | $428.44 62.82 USD | $25B 3.67B USD | 0 | -$15.13 -2.2 USD | |
| Vaxcyte, Inc. 5VA.MU | $26 28.42 USD |
-2.26
|
$3.35B 3.66B USD | $0 0 USD | $26 28.42 USD | $26 28.42 USD | $3.35B 3.66B USD | 0 | -$3.36 -3.6 USD | |
| Vaxcyte, Inc. 5VA.F | $25.4 27.77 USD |
-2.31
|
$3.27B 3.58B USD | $200 218.63 USD | $25.4 27.77 USD | $25.4 27.77 USD | $3.27B 3.58B USD | 0 | -$3.36 -3.6 USD | |
| 3SBio Inc. 83B.F | $1.33 1.45 USD |
-0.75
|
$3.25B 3.55B USD | $432 472.23 USD | $1.31 1.43 USD | $1.33 1.45 USD | $3.25B 3.55B USD | 13.30 | $0.1 0.11 USD | |
| Syngene International Limited SYNGENE.BO | $727.1 8.8 USD |
-0.27
|
$291.83B 3.53B USD | $8.36K 101.15 USD | $722.7 8.74 USD | $738.85 8.94 USD | $291.83B 3.53B USD | 58.30 | $12.47 0.15 USD | |
| Camurus AB (publ) 7CA.F | $50.2 54.88 USD |
-3.09
|
$2.96B 3.23B USD | $12 13.12 USD | $50.2 54.88 USD | $50.2 54.88 USD | $2.96B 3.23B USD | 77.23 | $0.65 0.71 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $30.8 33.67 USD |
+0.65
|
$2.93B 3.2B USD | $191 208.79 USD | $30.8 33.67 USD | $30.8 33.67 USD | $2.93B 3.2B USD | 0 | -$5.57 -6.08 USD | |
| Galapagos NV GXE.DE | $44.47 48.61 USD |
0
|
$2.93B 3.2B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.93B 3.2B USD | 0 | $0 0 USD | |
| Zai Lab Limited 1ZL.F | $25.4 27.77 USD |
+0.79
|
$2.91B 3.19B USD | $230 251.42 USD | $25.4 27.77 USD | $25.4 27.77 USD | $2.91B 3.19B USD | 0 | -$2.3 -2.5 USD | |
| VitaSpring Biomedical VSBC | $1 — |
0
|
$3.1B — | $100 — | $1 — | $1 — | $3.1B — | 0 | $0 — | |
| Genscript Biotech GNNSF | $1.3 — |
0
|
$2.92B — | $750 — | $1.3 — | $1.3 — | $2.92B — | 0 | -$0.08 — | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $4.8 5.25 USD |
+1.27
|
$2.66B 2.9B USD | $4 4.37 USD | $4.8 5.25 USD | $4.8 5.25 USD | $2.66B 2.9B USD | 15.00 | $0.32 0.35 USD | |
| Akero Therapeutics, Inc. 0K4.F | $32.99 36.06 USD |
+0.18
|
$2.64B 2.89B USD | $183 200.04 USD | $32.99 36.06 USD | $32.99 36.06 USD | $2.64B 2.89B USD | 0 | -$3.32 -3.6 USD | |
| Morphic Holding MORF | $56.99 — |
0
|
$2.86B — | $0 — | $0 — | $0 — | $2.86B — | 0 | $0 — | |
| MorphoSys AG MOR | $18.96 — |
0
|
$2.86B — | $0 — | $0 — | $0 — | $2.86B — | 0 | $0 — | |
| MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
| Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
| Genscript Biotech Corporation G51.F | $1.15 1.26 USD |
-0.26
|
$2.58B 2.82B USD | $1K 1.09K USD | $1.15 1.26 USD | $1.15 1.26 USD | $2.58B 2.82B USD | 0 | -$0.07 -0.07 USD | |
| MorphoSys AG MOR.VI | $68.15 74.5 USD |
0
|
$2.57B 2.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.57B 2.81B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $49.38 53.98 USD |
+0.61
|
$2.55B 2.78B USD | $29 31.7 USD | $49.38 53.98 USD | $49.38 53.98 USD | $2.55B 2.78B USD | 18.49 | $2.67 2.92 USD | |
| MorphoSys AG MOR.DE | $67.25 73.51 USD |
0
|
$2.53B 2.77B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.53B 2.77B USD | 0 | $0 0 USD | |
| MorphoSys AG MPSYF | $73.27 — |
0
|
$2.76B — | $0 — | $0 — | $0 — | $2.76B — | 0 | $0 — | |
| Scholar Rock Holding Corporation 2QK.F | $26.2 28.64 USD |
+0.77
|
$2.52B 2.75B USD | $1.22K 1.33K USD | $26.2 28.64 USD | $26.2 28.64 USD | $2.52B 2.75B USD | 0 | -$2.19 -2.3 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $26 28.42 USD |
+0.78
|
$2.46B 2.69B USD | $60 65.59 USD | $26 28.42 USD | $26 28.42 USD | $2.46B 2.69B USD | 0 | -$3.27 -3.5 USD | |
| Merus N.V. 2GH.F | $34.2 37.39 USD |
-4.47
|
$2.45B 2.68B USD | $300 327.94 USD | $34.2 37.39 USD | $36 39.35 USD | $2.45B 2.68B USD | 0 | -$2.97 -3.2 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $29.8 32.58 USD |
+4.93
|
$2.4B 2.63B USD | $11 12.02 USD | $29.8 32.58 USD | $29.8 32.58 USD | $2.4B 2.63B USD | 0 | -$2.67 -2.9 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $19.41 21.21 USD |
-2.76
|
$2.37B 2.59B USD | $295 322.47 USD | $19.41 21.21 USD | $19.41 21.21 USD | $2.37B 2.59B USD | 16.72 | $1.16 1.27 USD | |
| MorphoSys AG 0NDV.IL | $67.6 73.9 USD |
0
|
$2.34B 2.56B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.34B 2.56B USD | 0 | $0 0 USD | |
| Viking Therapeutics, Inc. 1VT.F | $19.72 21.56 USD |
-3.79
|
$2.26B 2.47B USD | $6 6.56 USD | $19.72 21.56 USD | $20.21 22.09 USD | $2.26B 2.47B USD | 0 | -$0.89 -0.9 USD | |
| Veracyte, Inc. 12V.F | $27.6 30.17 USD |
0
|
$2.18B 2.38B USD | $32 34.98 USD | $27.6 30.17 USD | $27.6 30.17 USD | $2.18B 2.38B USD | 102.22 | $0.27 0.3 USD | |
| ABL Bio Inc. 298380.KQ | $64,900 48.99 USD |
+2.53
|
$3.12T 2.35B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.12T 2.35B USD | 0 | $0 0 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $12.81 14 USD |
-1.23
|
$2.14B 2.34B USD | $2.28K 2.5K USD | $12.81 14 USD | $12.81 14 USD | $2.14B 2.34B USD | 10.67 | $1.2 1.31 USD | |
| SK bioscience Co.,Ltd. 302440.KS | $39,150 29.55 USD |
+1.69
|
$3.01T 2.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.01T 2.27B USD | 0 | $0 0 USD | |
| Bavarian Nordic A/S BV3.DE | $25.3 27.66 USD |
0
|
$1.99B 2.18B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.99B 2.18B USD | 0 | $0 0 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $15.39 16.82 USD |
-2.87
|
$1.96B 2.14B USD | $60 65.59 USD | $15.39 16.82 USD | $15.39 16.82 USD | $1.96B 2.14B USD | 0 | -$1.42 -1.5 USD | |
| ImmunityBio, Inc. 26CA.F | $2.12 2.32 USD |
-1.26
|
$1.91B 2.09B USD | $5.25K 5.74K USD | $2.12 2.31 USD | $2.16 2.36 USD | $1.91B 2.09B USD | 0 | -$0.55 -0.6 USD | |
| Bavarian Nordic A/S 0DPB.IL | $150.55 22.07 USD |
0
|
$14.13B 2.07B USD | $7.52K 1.1K USD | $150.7 22.1 USD | $150.7 22.1 USD | $14.13B 2.07B USD | 10.68 | $14.09 2.07 USD | |
| Vericel Corporation ATQP.F | $36.2 39.57 USD |
+2.26
|
$1.85B 2.03B USD | $50 54.66 USD | $36.2 39.57 USD | $36.2 39.57 USD | $1.85B 2.03B USD | 201.11 | $0.18 0.2 USD | |
| Amicus Therapeutics, Inc. AM6.F | $5.9 6.45 USD |
-0.84
|
$1.81B 1.98B USD | $73 79.8 USD | $5.9 6.45 USD | $5.9 6.45 USD | $1.81B 1.98B USD | 0 | -$0.16 -0.1 USD | |
| Galapagos NV G1LP34.SA | $7.21 1.46 USD |
+0.84
|
$9.58B 1.94B USD | $29 5.88 USD | $7.15 1.45 USD | $7.21 1.46 USD | $9.58B 1.94B USD | 0 | -$0.01 -0.002 USD | |
| Everest Medicines Limited 6HN.F | $5.25 5.74 USD |
+1.94
|
$1.76B 1.92B USD | $50 54.66 USD | $5.25 5.74 USD | $5.25 5.74 USD | $1.76B 1.92B USD | 0 | -$0.39 -0.4 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $89.5 97.84 USD |
-2.19
|
$1.75B 1.91B USD | $20 21.86 USD | $89.5 97.84 USD | $92.5 101.11 USD | $1.75B 1.91B USD | 0 | -$0.19 -0.2 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $33.2 36.29 USD |
-0.6
|
$1.69B 1.84B USD | $10 10.93 USD | $33.2 36.29 USD | $33.2 36.29 USD | $1.69B 1.84B USD | 0 | -$1.64 -1.7 USD | |
| Fusion Pharmaceuticals FUSN | $21.41 — |
0
|
$1.82B — | $0 — | $0 — | $0 — | $1.82B — | 0 | $0 — | |
| Bavarian Nordic A/S BVNKF | $22.8 — |
-0.87
|
$1.78B — | $100 — | $23 — | $23 — | $1.78B — | 11.87 | $1.92 — | |
| Ambrx Biopharma AMAM | $28 — |
0
|
$1.77B — | $0 — | $0 — | $0 — | $1.77B — | 0 | $0 — | |
| Denali Therapeutics Inc. 4DN.F | $11.03 12.06 USD |
-3.37
|
$1.6B 1.75B USD | $50 54.66 USD | $11.03 12.06 USD | $11.03 12.06 USD | $1.6B 1.75B USD | 0 | -$2.28 -2.4 USD | |
| Denali Therapeutics Inc. 4DN.MU | $11.01 12.03 USD |
-4.8
|
$1.6B 1.75B USD | $286 312.64 USD | $11.01 12.03 USD | $11.25 12.3 USD | $1.6B 1.75B USD | 0 | -$2.28 -2.4 USD | |
| Bavarian Nordic A/S BV3.F | $20.02 21.88 USD |
+1.01
|
$1.6B 1.74B USD | $10 10.93 USD | $20.02 21.88 USD | $20.71 22.64 USD | $1.6B 1.74B USD | 11.84 | $1.69 1.85 USD | |
| Genus GENSF | $25.1 — |
0
|
$1.65B — | $300 — | $25.1 — | $25.1 — | $1.65B — | 0 | -$0.08 — | |
| BB Biotech AG BIOEE.SW | $25.35 28.84 USD |
0
|
$1.45B 1.65B USD | $25K 28.44K USD | $25.25 28.73 USD | $26.25 29.87 USD | $1.45B 1.65B USD | 11.06 | $2.29 2.61 USD | |
| BioArctic AB (publ) 0RV2.IL | $168.4 16.44 USD |
+0.33
|
$16.85B 1.64B USD | $4.79K 467.37 USD | $166.5 16.25 USD | $172 16.79 USD | $16.85B 1.64B USD | 54.85 | $3.07 0.3 USD | |
| PeptiDream PPTDF | $12 — |
0
|
$1.63B — | $80 — | $11.21 — | $11.21 — | $1.63B — | 14.81 | $0.81 — | |
|
좋아하는 주식 없음
아직 즐겨찾는 주식이 없습니다. 여기에서 보려면 즐겨찾기에 추가하세요. |
||||||||||